General
Release from Glaxo Smith Kline (BIOC.CA) Concerning the Board of Directors & the Executive Managers
Published at 16 April 2026 at 15:51Glaxo Smith KlineRelated stock:Glaxo Smith Kline stockAll Glaxo Smith Kline disclosures
Disclosure summary
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
Release from the company concerning the Board of Directors & the Executive Managers.
Release from the Company (571 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
Release from the company concerning the Board of Directors & the Executive Managers.
Release from the Company (571 KB)